home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Understanding Schizophrenia

  November, 19 2009 18:53
your information resource in human molecular genetics

Dysfunction of neurotransmitter signalling can cause pathological behaviour similar to that seen in schizophrenia, according to a paper published online in the journal Nature Neuroscience. This finding may prove important for developing future therapeutic targets for disorders associated with psychosis.

Kazu Nakazawa and colleagues created a line of mice that lacked a particular functional receptor for the neurotransmitter glutamate in the inhibitory neurons located in brain regions responsible for cognitive function, emotion and memory. These mice developed various psychotic symptoms including changes in spatial working memory and increased anxiety. However, when the authors engineered the mice so that the receptor dysfunction would not occur until after adolescence, the mice showed no psychosis-like symptoms, suggesting that dysfunction of glutamate signalling specifically during development was responsible for the irregular behaviour.

Although there is thought to be a genetic contribution to schizophrenia, this disorder has not been linked to specific mutations in glutamate receptors. This mouse model aims to specifically test the 'glutamate' hypothesis in schizophrenia, which is based on evidence that various drugs of abuse that affect glutamate signalling also induce a variety of symptoms which are typically seen in schizophrenia, including social withdrawal and psychosis.

Regardless of whether these specific changes in glutamate transmission are found in human patients, this mouse model can be used to understand the changes that lead to psychotic behaviour.

Author contact:

Kazu Nakazawa (National Institute of Mental Health, Bethesda, MD, USA)
E-mail: nakazawk@mail.nih.gov

Abstract available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.